A carregar...

Objective evaluation of the role of vincristine in induction and maintenance therapy for myelomatosis. Medical Research Council Working Party on Leukaemia in Adults.

In the Medical Research Council's IVth trial in Myelomatosis the possible benefit of adding vincristine to first line treatment with intermittent melphalan and prednisone has been assessed. This was analysed in 530 patients who were randomly allocated to receive vincristine or not. Survival was...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: MacLennan, I. C., Cusick, J.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 1985
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1977102/
https://ncbi.nlm.nih.gov/pubmed/3896288
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!